Difference between revisions of "Template:Histamine receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
imported>Medgirl131 |
||
| Line 127: | Line 127: | ||
* [[Zepastine]]; ''3rd generation'': [[Desloratadine]] | * [[Zepastine]]; ''3rd generation'': [[Desloratadine]] | ||
* [[Fexofenadine]] | * [[Fexofenadine]] | ||
| − | * [[Levocetirizine]]; '' | + | * [[Levocetirizine]]; ''Unknown/unsorted'': [[Belarizine]] |
* [[Efletirizine]] | * [[Efletirizine]] | ||
* [[Elbanizine]] | * [[Elbanizine]] | ||
| Line 137: | Line 137: | ||
* [[Trelnarizine]] | * [[Trelnarizine]] | ||
* [[Trenizine]] | * [[Trenizine]] | ||
| − | * [[Vapitadine]]; ''Miscellaneous'': [[ | + | * [[Vapitadine]]; ''Miscellaneous'': [[Atypical antipsychotic]]s (e.g., [[aripiprazole]], [[asenapine]], [[clozapine]], [[iloperidone]], [[olanzapine]], [[paliperidone]], [[quetiapine]], [[risperidone]], [[ziprasidone]], [[zotepine]]) |
| − | + | * [[Tetracyclic antidepressant]]s (e.g., [[amoxapine]], [[loxapine]], [[maprotiline]], [[mianserin]], [[mirtazapine]], [[oxaprotiline]]) | |
| − | + | * [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]], [[butriptyline]], [[clomipramine]], [[desipramine]], [[dosulepin|dosulepin (dothiepin)]], [[doxepin]], [[imipramine]], [[iprindole]], [[lofepramine]], [[nortriptyline]], [[protriptyline]], [[trimipramine]]) | |
| − | * [[Tetracyclic antidepressant]]s ([[mianserin]], | + | * [[Typical antipsychotic]]s (e.g., [[chlorpromazine]], [[flupenthixol]], [[fluphenazine]], [[loxapine]], [[perphenazine]], [[prochlorperazine]], [[thioridazine]], [[thiothixene]]) |
| − | |||
| − | * [[ | ||
| − | |||
| − | * [[ | ||
| − | |||
| − | |||
| group2 = [[Histamine H2 receptor|H<sub>2</sub>]] | | group2 = [[Histamine H2 receptor|H<sub>2</sub>]] | ||
| Line 224: | Line 218: | ||
* [[VUF-8430]]<br/>'''Antagonists''': [[JNJ-7777120]] | * [[VUF-8430]]<br/>'''Antagonists''': [[JNJ-7777120]] | ||
* [[JNJ-38518168]] | * [[JNJ-38518168]] | ||
| + | * [[Mianserin]] | ||
* [[Thioperamide]] | * [[Thioperamide]] | ||
* [[VUF-6002]] | * [[VUF-6002]] | ||
| Line 246: | Line 241: | ||
* [[Amphetamine]] | * [[Amphetamine]] | ||
* [[Methamphetamine]] | * [[Methamphetamine]] | ||
| − | * [[ | + | * [[3,4-Methylenedioxymethamphetamine|MDMA]] |
* [[Phenethylamine]] | * [[Phenethylamine]] | ||
}} | }} | ||
Revision as of 22:17, 5 January 2015
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Histamine receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Histamine receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Histamine receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.